Compare UMH & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UMH | CERT |
|---|---|---|
| Founded | 1968 | 2008 |
| Country | United States | United States |
| Employees | 540 | N/A |
| Industry | Real Estate Investment Trusts | Retail: Computer Software & Peripheral Equipment |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | N/A | 2020 |
| Metric | UMH | CERT |
|---|---|---|
| Price | $15.70 | $6.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $17.75 | $11.67 |
| AVG Volume (30 Days) | 557.6K | ★ 4.6M |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | ★ 5.84% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,838,000.00 |
| Revenue This Year | $5.51 | $4.18 |
| Revenue Next Year | $2.51 | $5.39 |
| P/E Ratio | $203.74 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $13.93 | $4.45 |
| 52 Week High | $17.23 | $13.88 |
| Indicator | UMH | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 57.09 | 60.39 |
| Support Level | $15.64 | $6.45 |
| Resistance Level | $15.72 | $7.46 |
| Average True Range (ATR) | 0.27 | 0.41 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 54.90 | 70.66 |
UMH Properties Inc together with its subsidiaries, is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents. The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, it sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for its sites and homes, where the company is the lessor.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.